Toward the Development of an Injectable Dosage Form of Propofol: Preparation and Evaluation of Propofol–Sulfobutyl Ether 7‐β‐Cyclodextrin Complex

References

• Sharma A., Straubinger R. M. Novel taxol formulations: preparation and characterization of taxol‐containing liposomes. Pharm. Res. 1994; 11: 889–896
   PubMed Web of Science ®Google Scholar
• Tarr B. D., Sambandan T. G., Yalkowsky S. H. A new parenteral emulsion for the administration of taxol. Pharm. Res. 1987; 4: 162–165
   PubMed Web of Science ®Google Scholar
• Loftsson T., Brewster M. E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996; 85(10)1017–1025
   PubMed Web of Science ®Google Scholar
• Rajewski R. A., Stella V. J. Pharmaceutical applications of cyclodextrins. 2. Drug delivery. J. Pharm. Sci. 1996; 85(11)1142–1169
   PubMed Web of Science ®Google Scholar
• Sharma U. S., Balasubramanian S. V., Straubinger R. M. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J. Pharm. Sci. 1995; 84(10)1223–1230
   PubMed Web of Science ®Google Scholar
• Bhardwaj R., Dorr R. T., Blanchard J. Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrins. PDA J. Pharm. Sci. Technol. 2000; 54(3)233–239
   PubMedGoogle Scholar
• Trapani G., Lopedota A., Franco M., Latrofa A., Liso G. Effect of 2‐hydroxypropyl‐β‐cyclodextrin on the aqueous solubility of the anesthetic agent propofol (2,6‐diisopropylphenol). Int. J. Pharm. 1996; 139: 215–218
   Web of Science ®Google Scholar
• Trapani G., Latrofa A., Massimo F., Lopedota A., Sanna E., Liso G. Inclusion complexation of propofol with 2‐hydroxypropyl‐β‐cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies and anesthetic properties in rat. J. Pharm. Sci. 1998; 87(4)514–518
   PubMed Web of Science ®Google Scholar
• Szente L., Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties and trends in development. Adv. Drug Deliv. Rev. 1999; 36: 17–28
   PubMed Web of Science ®Google Scholar
• Ghorab M. K., Adeyeye M. C. Enhancement of ibuprofen dissolution via wet granulation with β‐cyclodextrin. Pharm. Dev. Technol. 2001; 6(3)305–314
   PubMed Web of Science ®Google Scholar
• Jain A. C., Adeyeye M. J. Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β‐cyclodextrins (SBE) and danazol‐SBE inclusion complexes. Int. J. Pharm. 2001; 212: 177–186
   PubMedGoogle Scholar
• Dollo G., Le Coree P., Chollet M., Chevanne F., Bertault M., Burgot J. L., Le Verge R. Improvement in solubility and dissolution rate of 1,2‐dithiole‐3‐thiones upon complexation with β‐cyclodextrin and its hydroxypropyl and sulfobutyl ether‐7 derivatives. J. Pharm. Sci. 1999; 88(9)889–895
   PubMed Web of Science ®Google Scholar
• Spamer E., Müller D. G., Wessels P. L., Venter J. P. Characterization of the complexes of furosemide with 2‐hydroxypropyl‐β‐cyclodextrin and sulfobutyl ether‐7‐b‐cyclodextrin. Eur. J. Pharm. Sci. 2002; 16: 247–253
   PubMed Web of Science ®Google Scholar
• Ficarra R., Ficarra P., Di Bella M. R., Raneri D., Tommasini S., Calabrò M. L., Villari A., Coppolino S. Study of the inclusion complex of atenolol with β‐cyclodextrins. J. Pharm. Biomed. Anal. 2000; 23: 231–236
   PubMed Web of Science ®Google Scholar
• Nagase Y., Hirata M., Wada K., Arima H., Hirayama F., Irie T., Kikuchi M., Uekama K. Improvement of some pharmaceutical properties of DY‐9760e by sulfobutyl ether β‐cyclodextrin. Int. J. Pharm. 2001; 229: 163–172
   PubMed Web of Science ®Google Scholar
• Miyake K., Irie T., Arima H., Hirayama F., Uekama K., Hirano M., Okamoto Y. Characterization of Itraconazole/2‐hydroxypropyl‐β‐cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm. 1999; 179: 237–245
   PubMed Web of Science ®Google Scholar
• Giordano F., Novak C., Moyano J. R. Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim. Acta 2001; 380: 123–151
   Web of Science ®Google Scholar
• Baker M. T., Gregerson M. S., Martin S. M., Buettner G. R. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite. Crit. Care. Med. 2003; 31(3)981–983
   PubMed Web of Science ®Google Scholar
• Higuchi T., Connors K. A. Phase solubility techniques. Adv. Anal. Chem. Instr. 1965; 4: 117–212
   Google Scholar
• Menard F. A., Dedhiya M. G., Rhodes C. T. Physico‐chemical aspects of complexation of some drugs with cyclodextrins. Drug Dev. Ind. Pharm. 1990; 16(1)91–113
   Web of Science ®Google Scholar
• Rekharsky M. V., Goldeberg R. N., Schwarz F. P., Tewari Y. B., Ross P. D., Yamashoji Y., Inoue Y. Thermodynamic and nuclear magnetic resonance study of the interactions of α‐ and β‐ cyclodextrin with model substances: phenethyl amine, ephedrines and related substances. J. Am. Chem. Soc. 1995; 117(34)8830–8840
   Web of Science ®Google Scholar
• Rekharsky M. V., Inoue Y. Complexation themodynamics of cyclodextrins. Chem. Rev. 1998; 98(5)1875–1917
   PubMed Web of Science ®Google Scholar
• Zia V., Rajewski R. A., Stella V. J. Thermodynamics of binding of neutral molecules to sulfobutyl ether b‐cyclodextrins (SBE‐β‐CDs): the effect of total degree of substitution. Pharm. Res. 2000; 17(8)936–941
   PubMed Web of Science ®Google Scholar
• Granero G., Longhi M. Thermal analysis and spectroscopic characterization of interactions between a naphthoquinone derivative with HP‐β‐CD or PVP. Pharm. Dev. Technol. 2002; 7(3)381–390
   PubMed Web of Science ®Google Scholar
• Bettinetti G. P., Sorrenti M., Rossi S., Ferrari F., Mura P., Faucci M. T. Assessment of solid‐state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J. Pharm. Biomed. Anal. 2002; 30: 1173–1179
   PubMed Web of Science ®Google Scholar
• Clas S.‐D., Dalton C. R., Hancock B. C. Differential scanning calorimetry: applications in drug development. Pharm. Sci. Technol. Today 1999; 2(8)311–320
   PubMedGoogle Scholar
• Coleman N. J., Craig D. Q.M. Modulated temperature differential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int. J. Pharm. 1996; 135: 13–29
   Web of Science ®Google Scholar
• Rabel S. R., Jona J. A., Maurin M. B. Applications of modulated differential calorimetry in preformulation studies. J. Pharm. Biomed. Anal. 1999; 21: 339–345
   PubMed Web of Science ®Google Scholar